(INNC)
IMMUNOGLOBULIN G1-KAPPA, ANTI-[HOMO SAPIENS PRLR (PROLACTIN RECEPTOR)], MONOCLONAL ANTIBODY; GAMMA1 HEAVY CHAIN (1-450) [VH (MUS MUSCULUS IGHV1- 69*02 (82.70%)/HOMO SAPIENS IGHV1-46*01 (79.6%) - (IGHD)-HOMO SAPIENS IGHJ6*01 (90.9%)) [8.8.13] (1-120) -HOMO SAPIENS IGHG1*03V, G1M3>G1M17, NG1M1 (CH1 R120>K (217) (121-218), HINGE (219-233), CH2 S3>C (242) (234-343), CH3 E12 (359), M14 (361) (344-448), CHS (449-450)) (121-450)], (223-214')-DISULFIDE WITH KAPPA LIGHT CHAIN (1'-214') [V-KAPPA (MUS MUSCULUS IGKV6- 13*01 (82.10%)/HOMO SAPIENS IGKV1-12*01 (81.1%) - HOMO SAPIENS IGKJ4*01 (100%)) [6.3.9] (1'-107') -HOMO SAPIENS IGKC*01, KM3 A45.1 (153), V101 (191) (108'- 214')]; DIMER (229-229":232-232")-BISDISULFIDE. PROPOSED INN: LIST 119(WHO)
ROLINSATAMABUM(INN)